--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About SLSR20260618C7.5
Metals and Mining
Solaris Resources Inc. was founded in Canada. Solaris is a late-stage clinical biopharmaceutical company focused on developing new treatments for a wide range of cancer indications. The company's product candidates currently include galinpepimuts (GPS), a peptide immunotherapy targeting the Wilms tumor 1 (WT1) antigen, and SLS009 (formerly known as GFH009), a highly selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
